Search

Memorial Sloan Kettering Cancer Center is one of six leading institutions that will share in a $120 million gift from a foundation created by American billionaire Daniel K. Ludwig.

… Tuesday, November 14, 2006 Memorial Sloan Kettering Cancer Center Among the Recipients Memorial Sloan Kettering Cancer Center is one of six leading institutions that will share in a $120 million gift from a foundation created by American billionaire Daniel K. Ludwig. Each of the six US centers will receive

A newly approved imaging technology can identify the location of prostate cancer cells, allowing doctors to choose the best treatment.

… Thursday, May 27, 2021 Prostate cancer diagnosis and treatment took a major step forward today as the US Food and Drug Administration approved an imaging technology that enables doctors to pinpoint the location of prostate cancer cells that would otherwise be hidden in the body. This new technology is

Metastasis is responsible for about 9 of every 10 cancer deaths, and it remains one of the most daunting and least understood aspects of the disease. Researchers across MSK are approaching a wide variety of metastatic cancer types from many directions.

… Friday, June 6, 2025 Sometimes doctors say that people don’t die from cancer, they die from metastasis — that is, from the spread of cancer from an initial “primary” tumor to other parts of the body. “We know how to control primary tumors — with surgery, chemotherapy, and radiation,” says physician-scientist

For more than a decade, Memorial Sloan Kettering Cancer Center’s (MSK) Visible Ink writing program has given a voice to more than 3,000 people with cancer, allowing each of them a unique opportunity to express themselves through interpretive dance, music, and poetry.

… Wednesday, March 23, 2022 For more than a decade, Memorial Sloan Kettering Cancer Center’s (MSK) Visible Ink writing program has given a voice to more than 3,000 people with cancer, allowing each of them a unique opportunity to express themselves through interpretive dance, music, and poetry. On Monday

In patients with progressive, refractory, or symptomatic desmoid tumors, sorafenib (Nexavar®) significantly improved progression-free survival (PFS) and induced durable responses. This study defined an active therapy for desmoid tumors that appears effective in slowing disease progression.

… Wednesday, December 19, 2018 Bottom Line: In patients with progressive, refractory, or symptomatic desmoid tumors , sorafenib (Nexavar ® ) significantly improved progression-free survival (PFS) and induced durable responses. This study defined an active therapy for desmoid tumors that appears effective

Patients with choroidal invasion of retinoblastoma can be successfully managed with ophthalmic artery chemosurgery (OAC) and avoid enucleation.

… Thursday, January 14, 2021 Patients with choroidal invasion of retinoblastoma can be successfully managed with ophthalmic artery chemosurgery (OAC) and avoid enucleation, according to our research published online first in Ophthalmology Retina . Worldwide, removing the affected eye has been the standard

可通过眼动脉化学外科 (OAC) 方式对视网膜母细胞瘤伴脉络膜侵犯的患者进行成功治疗，避免眼球摘除。

… Thursday, January 14, 2021 我们首次在线发表在 《眼科视网膜》(Ophthalmology Retina) 上的研究表明，对视网膜母细胞瘤伴脉络膜侵犯的患者，可以通过眼动脉化学外科 (OAC) 方式进行成功治疗，避免眼球摘除。 在世界范围内，摘除受累一侧的眼球一直是管理脉络膜浸润的标准方式。 近期，有很多临床医生开始质疑视网膜母细胞瘤伴脉络膜浸润是否真正有较高的转移率，患者是否有必要进行眼球摘除和多药辅助全身化疗的高强度治疗。  (1) 我们对包含 4 例双侧视网膜母细胞瘤儿童患者的小型病例系列进行了一项回顾性综述，这些患者均伴随有大量直径大于 3 毫米的脉络膜浸润病灶

A new imaging approach involving lasers and sound waves produces high-resolution pictures of tumor blood vessels.

… Wednesday, March 18, 2020 Summary Cancer drugs targeting the blood vessels that nourish tumors have shown mixed results. A new laser-based, high-resolution imaging technique could be a noninvasive tool for showing how these blood vessels change in response to therapy. Cancer needs a steady supply of

MSK is celebrating National Nurses Week, which runs from May 6 to 12 every year – the end date coinciding with Florence Nightingale's birthday.

… Friday, May 8, 2020 MSK Celebrates National Nurses Week Kevin Browne MSK is celebrating National Nurses Week, which runs from May 6 to 12 every year – the end date coinciding with Florence Nightingale’s birthday. This year marks the 200 th anniversary of her birth, prompting the World Health Organization

Learn how MSK’s liquid biopsy test, MSK-ACCESS, could improve the lives of patients with gynecologic cancers.

… Wednesday, July 26, 2023 Liquid biopsies have the potential to revolutionize cancer diagnosis and treatment decisions. Unlike biopsies that require removing tumor tissue, these tests use a simple blood draw to assess the molecular characteristics of cancer. Liquid biopsies can be done repeatedly and